{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:29:58Z","timestamp":1790879398189,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Universit\u00e9 Paris Cit\u00e9"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>Is preimplantation genetic testing for mitochondrial DNA (mtDNA) disorders (PGT-mt) feasible at early compaction and blastocyst stages?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>Pathogenic mtDNA variants segregate evenly among cell types and various lineages of a given embryo during preimplantation development, supporting the relevance of genetic analyses performed on Day 4 blastomere and on Day 5 or 6 trophectoderm (TE) samples.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>PGT-mt is validated at cleavage stage (Day 3 of development). However, its feasibility at later stages is questionable, as little is known regarding the segregation of pathogenic mtDNA variants during preimplantation development. Since mtDNA replication is silenced until the blastocyst stage (Day 5 or 6), uneven mtDNA segregation between preimplantation embryo cellular lineages known as a \u2018bottleneck\u2019 effect, cannot be excluded, posing a challenge for PGT-mt.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>We analyzed 112 \u2018mito\u2019 embryos carrying pathogenic mtDNA variants and 28 control embryos with mtDNA polymorphism. Heteroplasmy levels were assessed in single cells of the TE, in different parts of blastocysts (inner cell mass and TE), and at three time points of development, namely cleavage (Day 3), early compaction (Day 4), and blastocyst stages (Day 5 or 6).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>As part of clinical PGT, a blastomere biopsy was performed at cleavage or early compaction stages (Day 3 or 4) on 112 \u2018mito\u2019 and 21\/28 control embryos. Further analysis was carried out at Day 5 or 6 on 51 embryos deemed unsuitable for uterine transfer and donated to research. Heteroplasmy levels were determined by semi-quantitative PCR amplification of (i) the mtDNA pathogenic variants with additional enzymatic digestion or (ii) the mtDNA polymorphic hypervariable region 2.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>Here, we first show that mtDNA variants segregate evenly among blastomeres during early compaction (Day 4), supporting the feasibility of PGT-mt at this stage. We also found that mtDNA ratios remain stable between cleavage and blastocyst stages. Yet, the substantial variation of heteroplasmy levels occurring among single TE cells in 1\/8 embryos suggests that PGT is only feasible when at least 5\u201310 cells are collected by standard TE biopsy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>This study sheds light on mtDNA segregation in human preimplantation embryo development. Its limitation lies in the scarcity of the material and the small number of embryos carrying a specific pathogenic mtDNA variant. Furthermore, the study of single cells from TE was performed on control embryos only.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>By supporting the relevance of blastocyst biopsy in the context of PGT for pathogenic mtDNA variants, this study contributes to the general trend of postponing the biopsy to later stages of embryonic development. However, particular attention should be paid to the number of TE cells tested. Due to the potential variation of mutant load during in utero development, a control amniocentesis for evolutive pregnancies following the transfer of heteroplasmic embryos is still recommended.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>This work was funded by \u2018Association Fran\u00e7aise contre les Myopathies\/AFM T\u00e9l\u00e9thon\u2019 (22112, 24317, 28525); and EUR G.E.N.E. (No. ANR-17-EURE-0013). The authors have no competing interests to declare.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>N\/A.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humrep\/deaf050","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T12:18:39Z","timestamp":1742213919000},"page":"956-961","source":"Crossref","is-referenced-by-count":8,"title":["Profiling mitochondrial DNA variant segregation during human preimplantation development: a prerequisite to preimplantation genetic testing for mitochondrial DNA-related disorders"],"prefix":"10.1093","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4572-4066","authenticated-orcid":false,"given":"Paula","family":"Rubens","sequence":"first","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, Imagine Institute, Genetics of Mitochondrial Diseases, INSERM UMR 1163 , Paris,","place":["France"]},{"name":"Molecular Genetic Unit, AP-HP, Necker\u2014Enfants Malades Hospital , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5764-5382","authenticated-orcid":false,"given":"Anne","family":"Mayeur","sequence":"additional","affiliation":[{"name":"Reproductive Biology Unit\u2014CECOS, AP-HP, Antoine B\u00e9cl\u00e8re Hospital , Clamart,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1441-3450","authenticated-orcid":false,"given":"Kalliopi","family":"Chatzovoulou","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, Imagine Institute, Genetics of Mitochondrial Diseases, INSERM UMR 1163 , Paris,","place":["France"]},{"name":"Molecular Genetic Unit, AP-HP, Necker\u2014Enfants Malades Hospital , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Gigarel","sequence":"additional","affiliation":[{"name":"Molecular Genetic Unit, AP-HP, Necker\u2014Enfants Malades Hospital , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Monnot","sequence":"additional","affiliation":[{"name":"Molecular Genetic Unit, AP-HP, Necker\u2014Enfants Malades Hospital , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0589-0703","authenticated-orcid":false,"given":"Agn\u00e8s","family":"R\u00f6tig","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, Imagine Institute, Genetics of Mitochondrial Diseases, INSERM UMR 1163 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Munnich","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, Imagine Institute, Genetics of Mitochondrial Diseases, INSERM UMR 1163 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Frydman","sequence":"additional","affiliation":[{"name":"Reproductive Biology Unit\u2014CECOS, AP-HP, Antoine B\u00e9cl\u00e8re Hospital , Clamart,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5259-4144","authenticated-orcid":false,"given":"Julie","family":"Steffann","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, Imagine Institute, Genetics of Mitochondrial Diseases, INSERM UMR 1163 , Paris,","place":["France"]},{"name":"Molecular Genetic Unit, AP-HP, Necker\u2014Enfants Malades Hospital , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"2025050201522411000_deaf050-B1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/rmb2.12318","article-title":"Trophectoderm biopsy for preimplantation genetic test and technical tips: a review","volume":"19","author":"Aoyama","year":"2020","journal-title":"Reprod Med Biol"},{"key":"2025050201522411000_deaf050-B2","doi-asserted-by":"crossref","first-page":"102718","DOI":"10.1016\/j.jogoh.2023.102718","article-title":"PGT and deferred embryo transfer: is blastocyst biopsy more effective than cleaved embryo biopsy?","volume":"53","author":"Arroja","year":"2024","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"2025050201522411000_deaf050-B3","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s10815-016-0813-2","article-title":"Blastomere biopsy for PGD delays embryo compaction and blastulation: a time-lapse microscopic analysis","volume":"33","author":"Bar-El","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"2025050201522411000_deaf050-B4","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/jnnp.74.9.1188","article-title":"Mitochondria","volume":"74","author":"Chinnery","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2025050201522411000_deaf050-B5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1017\/S0967199418000084","article-title":"Transition from blastomere to trophectoderm biopsy: comparing two preimplantation genetic testing for aneuploidies strategies","volume":"26","author":"Coll","year":"2018","journal-title":"Zygote"},{"key":"2025050201522411000_deaf050-B6","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/humrep\/dex265","article-title":"ESHRE PGD Consortium data collection XIV\u2013XV: cycles from January 2011 to December 2012 with pregnancy follow-up to October 2013","volume":"32","author":"De Rycke","year":"2017","journal-title":"Hum Reprod"},{"key":"2025050201522411000_deaf050-B7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41556-017-0017-8","article-title":"Segregation of mitochondrial DNA heteroplasmy through a development genetic bottleneck in human embryos","volume":"20","author":"Floros","year":"2018","journal-title":"Nat Cell Biol"},{"key":"2025050201522411000_deaf050-B8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ymgme.2004.10.008","article-title":"Single cell quantification of the 8993T&gt;G NARP mitochondrial DNA mutation by fluorescent PCR","volume":"84","author":"Gigarel","year":"2005","journal-title":"Mol Genet Metab"},{"key":"2025050201522411000_deaf050-B9","doi-asserted-by":"crossref","first-page":"eadi4038","DOI":"10.1126\/sciadv.adi4038","article-title":"High-throughput single-cell analysis reveals progressive mitochondrial DNA mosaicism throughout life","volume":"9","author":"Glynos","year":"2023","journal-title":"Sci Adv"},{"key":"2025050201522411000_deaf050-B10","doi-asserted-by":"crossref","first-page":"16080","DOI":"10.1038\/nrdp.2016.80","article-title":"Mitochondrial diseases","volume":"2","author":"Gorman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2025050201522411000_deaf050-B11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mito.2014.08.005","article-title":"Mutation-free baby born from a mitochondrial encephalopathy, lactic acidosis and stroke-like syndrome carrier after blastocyst trophectoderm preimplantation genetic diagnosis","volume":"18","author":"Heindryckx","year":"2014","journal-title":"Mitochondrion"},{"key":"2025050201522411000_deaf050-B151","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/humupd\/dms008","article-title":"PGD and heteroplasmic mitochondrial DNA point mutations: a systematic review estimating the chance of healthy offspring","volume":"18","author":"Hellebrekers","year":"2012","journal-title":"Hum Reprod Update"},{"key":"2025050201522411000_deaf050-B12","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1038\/s41467-024-51508-1","article-title":"Clinical-grade whole genome sequencing-based haplarithmisis enables all forms of preimplantation genetic testing","volume":"15","author":"Janssen","year":"2024","journal-title":"Nat Commun"},{"key":"2025050201522411000_deaf050-B13","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1007\/s10815-021-02354-3","article-title":"Preimplantation genetic diagnosis for a carrier with m.3697G\u2009&gt;\u2009A mitochondrial DNA mutation","volume":"38","author":"Ji","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"2025050201522411000_deaf050-B14","doi-asserted-by":"crossref","first-page":"e0278663","DOI":"10.1371\/journal.pone.0278663","article-title":"Transcriptomic signatures in trophectoderm and inner cell mass of human blastocysts classified according to developmental potential, maternal age and morphology","volume":"17","author":"Kai","year":"2022","journal-title":"PLoS One"},{"key":"2025050201522411000_deaf050-B15","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/humrep\/del506","article-title":"Blastocyst biopsy versus cleavage stage biopsy and blastocyst transfer for preimplantation genetic diagnosis of beta-thalassaemia: a pilot study","volume":"22","author":"Kokkali","year":"2007","journal-title":"Hum Reprod"},{"key":"2025050201522411000_deaf050-B16","doi-asserted-by":"crossref","first-page":"102363","DOI":"10.1016\/j.xpro.2023.102363","article-title":"Developmental-stage specific single-cell human embryo dissociation","volume":"4","author":"Lammers","year":"2023","journal-title":"STAR Protoc"},{"key":"2025050201522411000_deaf050-B17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/elps.200305681","article-title":"Quantitative and qualitative profiling of mitochondrial DNA length heteroplasmy","volume":"25","author":"Lee","year":"2004","journal-title":"Electrophoresis"},{"key":"2025050201522411000_deaf050-B18","first-page":"408","article-title":"Homopolymeric tract heteroplasmy in mtDNA from tissues and single oocytes: support for a genetic bottleneck","volume":"60","author":"Marchington","year":"1997","journal-title":"Am J Hum Genet"},{"key":"2025050201522411000_deaf050-B19","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.celrep.2014.05.004","article-title":"Limitations of preimplantation genetic diagnosis for mitochondrial DNA diseases","volume":"7","author":"Mitalipov","year":"2014","journal-title":"Cell Rep"},{"key":"2025050201522411000_deaf050-B20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/humu.21417","article-title":"Segregation of mtDNA throughout human embryofetal development: m.3243A&gt;G as a model system","volume":"32","author":"Monnot","year":"2011","journal-title":"Hum Mutat"},{"key":"2025050201522411000_deaf050-B21","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/hmg\/ddt040","article-title":"Mutation dependance of the mitochondrial DNA copy number in the first stages of human embryogenesis","volume":"22","author":"Monnot","year":"2013","journal-title":"Hum Mol Genet"},{"key":"2025050201522411000_deaf050-B22","doi-asserted-by":"crossref","first-page":"e0238599","DOI":"10.1371\/journal.pone.0238599","article-title":"Is day-4 morula biopsy a feasible alternative for preimplantation genetic testing?","volume":"15","author":"Orvieto","year":"2020","journal-title":"PLoS One"},{"key":"2025050201522411000_deaf050-B23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3390\/life11070633","article-title":"mtDNA heteroplasmy: origin, detection, significance, and evolutionary consequences","volume":"11","author":"Parakatselaki","year":"2021","journal-title":"Life"},{"key":"2025050201522411000_deaf050-B24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/jmedgenet-2017-104633","article-title":"Preimplantation genetic diagnosis for mitochondrial DNA mutations: analysis of one blastomere suffices","volume":"54","author":"Sallevelt","year":"2017","journal-title":"J Med Genet"},{"key":"2025050201522411000_deaf050-B25","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.fertnstert.2013.04.039","article-title":"Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial","volume":"100","author":"Scott","year":"2013","journal-title":"Fertil Steril"},{"key":"2025050201522411000_deaf050-B26","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/hmg\/ddr043","article-title":"Neutral mitochondrial heteroplasmy and the influence of aging","volume":"20","author":"Sondheimer","year":"2011","journal-title":"Hum Mol Genet"},{"key":"2025050201522411000_deaf050-B27","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.fertnstert.2021.01.026","article-title":"Clinical application of sequencing-based methods for parallel preimplantation genetic testing for mitochondrial DNA disease and aneuploidy","volume":"115","author":"Spath","year":"2021","journal-title":"Fertil Steril"},{"key":"2025050201522411000_deaf050-B28","doi-asserted-by":"crossref","first-page":"hoad010","DOI":"10.1093\/hropen\/hoad010","article-title":"ESHRE PGT Consortium data collection XXI: PGT analyses in 2018","volume":"2023","author":"Spinella","year":"2023","journal-title":"Hum Reprod Open"},{"key":"2025050201522411000_deaf050-B29","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jmg.2005.032326","article-title":"Analysis of mtDNA variant segregation during early human embryonic development: a tool for successful NARP preimplantation diagnosis","volume":"43","author":"Steffann","year":"2006","journal-title":"J Med Genet"},{"key":"2025050201522411000_deaf050-B30","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.celrep.2014.05.005","article-title":"Data from artificial models of mitochondrial DNA disorders are not always applicable to humans","volume":"7","author":"Steffann","year":"2014","journal-title":"Cell Rep"},{"key":"2025050201522411000_deaf050-B31","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/cge.12557","article-title":"mtDNA mutations variously impact mtDNA maintenance throughout the human embryofetal development","volume":"88","author":"Steffann","year":"2015","journal-title":"Clin Genet"},{"key":"2025050201522411000_deaf050-B32","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41436-020-01043-3","article-title":"A retrospective study on the efficacy of prenatal diagnosis for pregnancies at risk of mitochondrial DNA disorders","volume":"23","author":"Steffann","year":"2021","journal-title":"Genet Med"},{"key":"2025050201522411000_deaf050-B33","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.fertnstert.2012.07.1119","article-title":"Blastocyst preimplantation genetic diagnosis (PGD) of a mitochondrial DNA disorder","volume":"98","author":"Treff","year":"2012","journal-title":"Fertil Steril"},{"key":"2025050201522411000_deaf050-B152","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/jmedgenet-2017-104615","article-title":"Segregation of mitochondrial DNA mutations in the human placenta: implication for prenatal diagnosis of mtDNA disorders","volume":"55","author":"Vachin","year":"2018","journal-title":"J Med Genet"},{"key":"2025050201522411000_deaf050-B34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s11626-013-9713-2","article-title":"A simple and effective method for the isolation of inner cell mass samples from human blastocysts for gene expression analysis","volume":"50","author":"Xu","year":"2014","journal-title":"In Vitro Cell Dev Biol Anim"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/40\/5\/956\/62845485\/deaf050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/40\/5\/956\/62845485\/deaf050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T05:52:55Z","timestamp":1746165175000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/40\/5\/956\/8104258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,4,2]]},"published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deaf050","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,4,2]]}}}